Source: http://www.law.cornell.edu/cfr/text/21/26/subpart-A/appendix-D
Timestamp: 2013-05-25 06:14:55
Document Index: 29857943

Matched Legal Cases: ['art 26', 'art 26', 'art 26', 'art 26', '§ 552', '§ 1453', '§ 1454', '§ 1455', '§ 1905', '§ 321', '§ 331', '§ 351', '§ 352', '§ 355', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 371', '§ 374', '§ 381', '§ 382', '§ 383', '§ 393', '§ 216', '§ 241', '§ 262', '§ 264', '§ 265']

21 CFR 26, Subpart A, Appendix D to Subpart A of Part 26 - Criteria for Assessing Equivalence for Post- and Preapproval | Title 21 - Food and Drugs | Code of Federal Regulations | LII / Legal Information Institute
CFR › Title 21 › Chapter I › Subchapter A › Part 26 › Subpart A › Appendix D	prev | next
21 CFR 26, Subpart A, Appendix D to Subpart A of Part 26 - Criteria for Assessing Equivalence for Post- and Preapproval
Pt. 26, Subpt. A, App. D
Appendix D to Subpart A of Part 26—Criteria for Assessing Equivalence for Post- and Preapproval
I. Legal/Regulatory authority and structures and procedures providing for post- and preapproval:
A. Appropriate statutory mandate and jurisdiction.
B. Ability to issue and update binding requirements on GMP's and guidance documents.
C. Authority to make inspections, review and copy documents, and to take samples and collect other evidence.
D. Ability to enforce requirements and to remove products found in violation of such requirements from the market.
E. Substantive current good manufacturing requirements.
F. Accountability of the regulatory authority.
G. Inventory of current products and manufacturers.
H. System for maintaining or accessing inspection reports, samples and other analytical data, and other firm/product information relating to matters covered by subpart A of this part.
II. Mechanisms in place to assure appropriate professional standards and avoidance of conflicts of interest.
III. Administration of the regulatory authority:
A. Standards of education/qualification and training.
B. Effective quality assurance systems measures to ensure adequate job performance.
C. Appropriate staffing and resources to enforce laws and regulations.
IV. Conduct of inspections:
A. Adequate preinspection preparation, including appropriate expertise of investigator/team, review of firm/product and databases, and availability of appropriate inspection equipment.
B. Adequate conduct of inspection, including statutory access to facilities, effective response to refusals, depth and competence of evaluation of operations, systems and documentation; collection of evidence; appropriate duration of inspection and completeness of written report of observations to firm management.
C. Adequate postinspection activities, including completeness of inspectors' report, inspection report review where appropriate, and conduct of followup inspections and other activities where appropriate, assurance of preservation and retrieval of records.
V. Execution of regulatory enforcement actions to achieve corrections, designed to prevent future violations, and to remove products found in violation of requirements from the market.
VI. Effective use of surveillance systems:
A. Sampling and analysis.
B. Recall monitoring.
C. Product defect reporting system.
D. Routine surveillance inspections.
E. Verification of approved manufacturing process changes to marketing authorizations/approved applications.
VII. Additional specific criteria for preapproval inspections:
A. Satisfactory demonstration through a jointly developed and administered training program and joint inspections to assess the regulatory authorities' capabilities.
B. Preinspection preparation includes the review of appropriate records, including site plans and drug master file or similar documentation to enable adequate inspections.
C. Ability to verify chemistry, manufacturing, and control data supporting an application is authentic and complete.
D. Ability to assess and evaluate research and development data as scientifically sound, especially transfer technology of pilot, scale up and full scale production batches.
E. Ability to verify conformity of the onsite processes and procedures with those described in the application.
F. Review and evaluate equipment installation, operational and performance qualification data, and evaluate test method validation.
Title 21 published on 2012-04-01no entries appear in the Federal Register after this date. This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.United States CodeUSC : Title 5 - GOVERNMENT ORGANIZATION AND EMPLOYEES§ 552 - Public information; agency rules, opinions, orders, records, and proceedings
USC : Title 15 - COMMERCE AND TRADE§ 1453 - Requirements of labeling; placement, form, and contents of statement of quantity; supplemental statement of quantity§ 1454 - Rules and regulations§ 1455 - Procedure for promulgation of regulations
USC : Title 18 - CRIMES AND CRIMINAL PROCEDURE§ 1905 - Disclosure of confidential information generally
USC : Title 21 - FOOD AND DRUGS§ 321 - Definitions; generally§ 331 - Prohibited acts§ 351 - Adulterated drugs and devices§ 352 - Misbranded drugs and devices§ 355 - New drugs§ 360 - Registration of producers of drugs or devices§ 360b - New animal drugs§ 360c - Classification of devices intended for human use§ 360d - Performance standards§ 360e - Premarket approval21 USC § 360e–1 - Pediatric uses of devices§ 360f - Banned devices§ 360g - Judicial review§ 360h - Notification and other remedies§ 360i - Records and reports on devices§ 360j - General provisions respecting control of devices intended for human use21 USC § - § 360m - Accredited persons§ 371 - Regulations and hearings§ 374 - Inspection§ 381 - Imports and exports§ 382 - Exports of certain unapproved products§ 383 - Office of International Relations§ 393 - Food and Drug Administration
U.S.C. : Title 42 - THE PUBLIC HEALTH AND WELFARE§ 216 - Regulations§ 241 - Research and investigations generally42 USC § - § 262 - Regulation of biological products§ 264 - Regulations to control communicable diseases§ 265 - Suspension of entries and imports from designated places to prevent spread of communicable diseases